Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

In Vitro Drug Dissolution: Compendial Testing Models I

In Vitro Drug Dissolution: Compendial Testing Models I

Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...

In Vitro Drug Dissolution: Compendial Testing Models II

In Vitro Drug Dissolution: Compendial Testing Models II

Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients, maintaining...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ultrastructural Study of Microphysiological Systems of the Tumor Microenvironment.

Small science·2026

Same author

Copper-Collagen Interactions Regulate the Mechanical and Invasive Properties of Tumor Spheroids.

Advanced healthcare materials·2026

Same author

Elevated interstitial fluid pressure promotes spheroid growth and reduces CAR-T therapeutic efficacy in solid tumors.

Acta biomaterialia·2026

Same author

Mutant calreticulin enables potent and selective CAR-T cell therapy in preclinical models of myeloproliferative neoplasms.

Journal for immunotherapy of cancer·2026

Same author

Local mechanobiological disruption in solid tumor-driven vascular permeability: A competition between mechanical vs chemical stimuli.

Acta biomaterialia·2026

Same author

Matrix composition and glucose availability cooperatively determine cancer spheroid bioenergetics in 3D hydrogels.

Cancer & metabolism·2025

Search research articles

Related Experiment Video

Updated: Jul 26, 2026

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Published on: November 20, 2011

Matrix-integrated microfluidic tumor models for evaluating drug delivery systems and pre-clinical testing.

Paula Guerrero-López¹, Pilar Alamán-Díez¹, Soraya Hernández-Hatibi¹

¹Multiscale in Mechanical and Biological Engineering, Aragón Institute of Engineering Research (I3A), University of Zaragoza, Zaragoza, Spain.

Advanced Drug Delivery Reviews

|February 22, 2026

Summary

Microfluidic tumor-on-chip platforms with extracellular matrix integration offer advanced models for evaluating drug delivery. These systems improve preclinical testing by mimicking the tumor microenvironment, enhancing therapeutic translation.

Keywords:

Drug delivery systems Matrix-integrated microfluidic model Transport dynamics Tumor-on-chip

More Related Videos

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research

Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research

Published on: September 15, 2023

Related Experiment Videos

Last Updated: Jul 26, 2026

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Published on: November 20, 2011

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research

Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research

Published on: September 15, 2023

Area of Science:

Biomedical Engineering
Drug Delivery
Cancer Research

Background:

Conventional experimental models for drug delivery face limitations in physiological relevance and translational predictability.
Microfluidic tumor-on-chip platforms offer a controlled environment to study the tumor microenvironment (TME).
Incorporating extracellular matrix (ECM) mimics enhances the fidelity of these in vitro models.

Purpose of the Study:

To review the application of microfluidic matrix-integrated tumor-on-chip platforms for drug delivery evaluation.
To discuss the engineering of TME features within microfluidic models.
To examine the assessment of various therapeutic strategies using these advanced platforms.

Main Methods:

Focus on microfluidic platforms engineered with ECM mimics to replicate solid tumor characteristics.
Analysis of how transport dynamics and delivery mechanisms are modeled under physiologically relevant conditions.
Review of therapeutic strategies evaluated, including nanocarriers, biologics, and cell-based therapies.

Main Results:

Matrix-integrated tumor-on-chip platforms provide enhanced physiological relevance for drug delivery studies.
These models allow for the investigation of drug penetration, transport dynamics, and therapeutic responses.
Demonstrated utility in assessing diverse therapeutic modalities and improving preclinical predictions.

Conclusions:

Microfluidic matrix-integrated tumor-on-chip technologies are powerful preclinical tools for drug delivery evaluation.
These platforms bridge the gap between in vitro assays and in vivo studies.
They accelerate the translation of drug delivery systems and support personalized medicine.